Palvella Therapeutics Inc (PVLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Sales | 1,247 | 2,140 | 415 | 160 | 218 |
| Gross Profit | 1,247 | 2,140 | 415 | 160 | 218 |
| Operating Expenses | 5,627 | 4,705 | 4,295 | 3,695 | 3,919 |
| Operating Income | -4,381 | -2,565 | -3,880 | -3,534 | -3,701 |
| Interest Expense | 0 | 180 | 0 | 0 | 4 |
| Other Income | 220 | 8 | -2 | 5 | 1 |
| Pre-tax Income | -4,161 | -2,738 | -3,882 | -3,530 | -3,705 |
| Income Tax | N/A | 163 | 40 | N/A | N/A |
| Net Income Continuous | -4,161 | -2,902 | -3,922 | -3,530 | -3,705 |
| Net Income | $-4,161 | $-2,902 | $-3,922 | $-3,530 | $-3,705 |
| EPS Basic Total Ops | -8.00 | -4.80 | -8.00 | -9.60 | -10.40 |
| EPS Basic Continuous Ops | -8.36 | -4.92 | -8.07 | -9.60 | -10.12 |
| EPS Diluted Total Ops | -8.00 | -4.80 | -8.00 | -9.60 | -10.40 |
| EPS Diluted Continuous Ops | -8.36 | -4.92 | -8.07 | -9.60 | -10.12 |
| EBITDA(a) | $-4,286 | $-2,492 | $-3,800 | $-3,458 | $-3,623 |